Trans-cinnamaldehyde protects against phenylephrine-induced cardiomyocyte hypertrophy through the CaMKII/ERK pathway
Abstract Background Trans-cinnamaldehyde (TCA) is one of the main pharmaceutical ingredients of Cinnamomum cassia Presl, which has been shown to have therapeutic effects on a variety of cardiovascular diseases. This study was carried out to characterize and reveal the underlying mechanisms of the pr...
Saved in:
Main Authors: | Dongdong Qian (Author), Jing Tian (Author), Sining Wang (Author), Xiaoli Shan (Author), Pei Zhao (Author), Huihua Chen (Author), Ming Xu (Author), Wei Guo (Author), Chen Zhang (Author), Rong Lu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanisms of CaMKII Activation
by: Jeffrey R Erickson
Published: (2014) -
Enhanced Cardiac CaMKII Oxidation and CaMKII-Dependent SR Ca Leak in Patients with Sleep-Disordered Breathing
by: Michael Arzt, et al.
Published: (2022) -
CaMKII in Cardiac Health and Disease
by: Andrew G Edwards
Published: (2014) -
CaMKII regulation of cardiac K channels
by: Julian eMustroph, et al.
Published: (2014) -
Regulation of CaMKII signaling in cardiovascular disease
by: Mariya Yordanova Mollova, et al.
Published: (2015)